[Interim report of JFMC study no. 23--phase III randomized clinical trial on the effectiveness of low-dose cisplatin plus 5-FU as a postoperative adjuvant chemotherapy for advanced gastric cancer].
Shigetoyo Saji(Gifu University), Kiyoshi Inokuchi, Akira Gochi, Koichi Hirata(Japan Coal Energy Center), Suketami Tominaga(Aichi Cancer Center), Yasuhiko Kurosu, Tetsuya Toge(Hiroshima University)
PubMed
December 1, 2002
Cited by 2
Related Papers
Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines
|Journal of Hepato-Biliary-Pancreatic Surgery|2007|584
Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines
|Journal of Hepato-Biliary-Pancreatic Surgery|2007|489
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255